GI Cancer Institute

Beneficiary Profile

Changing outcomes for people with gastro-intestinal cancer

Every day, over 100 Australians will be told they have a gastro-intestinal (GI) cancer, which includes cancer of the liver, pancreas, large and small bowel, oesophagus, stomach, gallbladder, rectum and anus.

For more than 30 years, the GI Cancer Institute has been conducting clinical trials and translational research studies to improve treatments, survival rates and quality of life for people with GI cancer.

Their dedicated group of more than 1,800 researchers  encompasses a wide range of medical specialists, scientists, nurses, allied health professionals and community members with lived experience, working collaboratively to advance our knowledge of GI cancer.  

The GI Cancer Institute also raises awareness of GI cancer in the community and raises funds to conduct new GI cancer research.
Advancing Medical Research Through
Advancing Knowledge
Capacity Building
Health Impacts
Further Reading